Sonoma Pharma: Doubles in value on partnership for OTC products' sale

Sonoma Pharmaceuticals

11/12/2020 13:35

** Drug developer's  SNOA.O  shares more than double in
value to $14.03 premarket, highest in more than 6 months 
    ** Crown Laboratories to sell Sonoma's Microcyn
technology-based over-the-counter products like dermal sprays
and gels targeting itch and pain  urn:newsml:reuters.com:*:nBw7gTPKVa
    ** SNOA will continue to sell its prescription strength
products, while Crown will distribute an OTC version available
without prescription - SNOA
    ** SNOA stock up 40.5% this year, as of last close

 (Reporting by Shreyasee Raj in Bengaluru)
 ((Shreyasee.Raj@thomsonreuters.com;))